ArticlePolymer science & technology (Washington, D.C.)2025
Biodegradable, Biocompatible, and Crosslinkable Polymers Enable Biosafe and Sustainable Soft Gels and Nanogels for Biomedical Applications.
Article in Polymer science & technology (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biomimetic LHRH-targeted nanogels for spatiotemporal-enhanced chemo-dynamic therapy of cancer.Journal of nanobiotechnology · 2026Article
- Recent advances in hydrogel-based delivery systems for the treatment of pancreatic cancer.Materials today. Bio · 2025Review
- Multichannel 3D-Printed Bioactive Scaffold Combined with Small Interfering RNA Delivery to Promote Neurological Recovery after Spinal Cord Injury.Research (Washington, D.C.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To date, more biodegradable polymers have been developed due to the growing recognition of the advantages of biodegradable and biocompatible polymers for biomedical applications. In this study, we introduce the synthesis and characterization of innovative polymers that incorporate biodegradable backbones composed of trimethylolpropane and adipic acid moieties and biocleavable side chains containing pyridyl disulfide groups. Notably, their synthesis is straightforward and catalyst-free under ambient conditions, minimizing potential toxicity and immune responses caused by catalyst residues in polymer materials. The new polymers have desired molecular weight (Mn: 18.8 kDa) with a narrow dispersion (PDI: 1.32) and offer complete biodegradability, biocompatibility, crosslinking capabilities, and opportunities for covalent chemical modifications. These features make them particularly suitable for use in biomedical materials and devices. Additionally, due to their unique properties, these polymers have been successfully formulated into polymeric gels and nanogels, which are biodegradable as well. Using a near-infrared fluorescent probe as a model cargo, we demonstrated the creation of a biosafe and sustainable nanogel system for agent delivery, with an average size of approximately 70 nm. In these nanogels, agent molecules are covalently attached to the scaffold, thereby avoiding uncontrolled premature release and burst release in the bloodstream and mitigating associated systemic toxicity and side effects. The nanogels can also be easily functionalized with targeting ligands for disease-specific delivery. These polymers induced minimal toxicity toward human cells and displayed excellent in vivo biocompatibility, highlighting the significant potential of their polymeric gels and nanogels for a broad spectrum of biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.